Bell Investment Advisors, Inc Horizon Therapeutics Public LTD CO Transaction History

Bell Investment Advisors, Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	SELL	$98.98 - $115.74 $395 - $462	-4 Reduced 2.6%	150 $17,000
Q2 2023 Aug 09, 2023	SELL	$96.34 - $112.38 $770 - $899	-8 Reduced 4.94%	154 $15,000
Q1 2023 May 10, 2023	SELL	$107.32 - $113.5 $751 - $794	-7 Reduced 4.14%	162 $17,000
Q4 2022 Feb 08, 2023	BUY	$62.39 - $113.8 $5,615 - $10,242	90 Added 113.92%	169 $19,000
Q3 2022 Nov 09, 2022	BUY	$58.92 - $84.67 $1,414 - $2,032	24 Added 43.64%	79 $5,000

Q2 2022 Aug 12, 2022	SELL	$79.4 - $116.36 $1,667 - $2,443	-21 Reduced 27.63%	55 $4,000
Q4 2021 Feb 14, 2022	SELL	$98.56 - $119.91 $492 - $599	-5 Reduced 6.17%	76 $8,000
Q3 2021 Nov 12, 2021	BUY	$91.91 - $110.37 $7,444 - $8,939	81 New	81 $9,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Bell Investment Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Bell Investment Advisors, Inc with notifications on news.